Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase

被引：83
|
作者：
Böger, RH
Vallance, P
Cooke, JP
机构：
[1] Univ Hamburg, Hosp Eppendorf, Ctr Med Expt, Inst Expt & Clin Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany
[2] UCL, Dept Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England
[3] Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Program Vasc Med & Biol, Stanford, CA 94305 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 04期
关键词：
D O I：
10.1016/S1567-5688(03)00027-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine (ADMA): An endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule
    Colonna, Vito De Gennaro
    Bianchi, Mauro
    Pascale, Valerio
    Ferrario, Paolo
    Morelli, Franca
    Pascale, Walter
    Tomasoni, Livio
    Turiel, Maurizio
    MEDICAL SCIENCE MONITOR, 2009, 15 (04): : RA91 - RA101
  • [2] Cardiovascular effects of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and evidence for ADMA metabolism in humans in vivo
    Achan, V
    Broadhead, M
    Malaki, M
    Leiper, J
    MacAllister, R
    Vallance, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 303A - 303A
  • [3] Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as a novel cardiovascular risk factor
    Böger, R. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 22 - 23
  • [4] Hepatic inflammation exacerbates elevated portal pressure by increasing asymmetric dimethylarginine (ADMA), a regulator of endothelial nitric oxide synthase (eNOS) activity.
    Mookerjee, RP
    Malaki, M
    Sen, S
    Hodges, SJ
    Davies, NA
    Vaneijk, H
    Deutz, NE
    Williams, R
    Leiper, J
    Vallance, P
    Jalan, R
    HEPATOLOGY, 2004, 40 (04) : 484A - 485A
  • [5] Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice
    Gunduz, Ozgur
    Karadag, Cetin Hakan
    Ulugol, Ahmet
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (09) : 1027 - 1032
  • [6] Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, increases the risk of cardiovascular disease and mortality in humans
    Boger, RH
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14 (04): : A11 - A11
  • [7] Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease
    Schnog, JB
    Teerlink, T
    van der Dijs, FPL
    Duits, AJ
    Muskiet, FAJ
    ANNALS OF HEMATOLOGY, 2005, 84 (05) : 282 - 286
  • [8] Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease
    J. B. Schnog
    T. Teerlink
    F. P. L. van der Dijs
    A. J. Duits
    F. A. J. Muskiet
    Annals of Hematology, 2005, 84 : 282 - 286
  • [9] Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice
    Ozgur Gunduz
    Cetin Hakan Karadag
    Ahmet Ulugol
    Journal of Neural Transmission, 2010, 117 : 1027 - 1032
  • [10] Plasma Asymmetric Dimethylarginine (ADMA) and Nitric Oxide (NO) Levels in Patients with Chronic Pansinusitis
    Bulut, Fuat
    Tetiker, Aylin Turksever
    Celikkol, Aliye
    Safak, Aye Sezim
    Topcu, Birol
    Ballica, Basak
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 1591 - 1596
12345